TrialExperimental dermatology2025

Orismilast, a Potent and Selective PDE4B/D Inhibitor, Reduces Protein Levels of Key Disease Driving Cytokines in the Skin of Patients With Plaque Psoriasis.

Richard B Warren et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.